Ruconest (Tjoapack Netherlands BV)
Welcome to the PulseAid listing for the Ruconest drug offered from Tjoapack Netherlands BV. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Tjoapack Netherlands BV |
| NON-PROPRIETARY NAME: | c1 esterase inhibitor recombinant |
| SUBSTANCE NAME: | CONESTAT ALFA |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2016-09-19 |
| END MARKETING DATE: | 0000-00-00 |
Ruconest HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ruconest from Tjoapack Netherlands BV |
| LABELER NAME: | Tjoapack Netherlands BV |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2100(U/1) |
| START MARKETING DATE: | 2016-09-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69913-350_3cdf1975-2622-14f5-e054-00144ff8d46c |
| PRODUCT NDC: | 69913-350 |
| APPLICATION NUMBER: | BLA125495 |
Other CONESTAT ALFA Pharmaceutical Manufacturers / Labelers:
